Scott D. Findlay

发表

Quantifying negative selection in human 3ʹ UTRs uncovers constrained targets of RNA-binding proteins

C. Burge, Scott D. Findlay, Lindsay Romo, 2022, bioRxiv.

Assessing breast cancer cell lines as tumour models by comparison of mRNA expression profiles

Scott D. Findlay, L. Postovit, Krista M. Vincent, 2015, Breast Cancer Research.

Post-transcriptional regulation in cancer progression

L. Postovit, S. Findlay, Michael Jewer, 2012, Journal of Cell Communication and Signaling.

Application of Surface-Enhanced Raman Spectroscopy to Guide Therapy for Advanced Prostate Cancer Patients.

J. Lewis, D. Pink, M. McDermott, 2022, ACS sensors.

Brief Report: Common Genetic Variation in Chromosome 10 q22.1 Shows a Strong Sex Bias in Human Embryonic Stem Cell Lines and Directly Controls the Novel Alternative Splicing of Human NODAL which is Associated with XIST Expression in Female Cell Lines

L. Postovit, S. Findlay, Scott D. Findlay, 2016, Stem cells.

CellTrace™ Violet Flow Cytometric Assay to Assess Cell Proliferation.

Gabrielle M. Siegers, Scott D. Findlay, M. B. Lemieszek, 2022, Methods in molecular biology.

Regulatory features aid interpretation of 3’UTR Variants

C. Burge, Scott D. Findlay, Lindsay Romo, 2023, bioRxiv.

Cancer research meets evolutionary biology

Santa Fe Institute, T. Vincent, C. Findlay, 2009, Evolutionary applications.

RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma

D. Eisenstat, R. Godbout, A. Gamper, 2023, Molecular Oncology.

Regulatory features aid interpretation of 3'UTR variants.

Scott D. Findlay, Lindsay Romo, Christopher B Burge, 2024, American journal of human genetics.